B
진양제약
007370KOSDAQ64.5 / 100
Reference Date: 2026-09-08
Financial Score35.0 / 40
News Sentiment12.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly up 1.9% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Jinyang Pharmaceutical primarily engages in the manufacturing and sales of pharmaceutical products, operating in a high-value, R&D-driven industry. However, growth is constrained by government price controls and intensified competition, with new drug development and international market expansion seen as key future growth drivers.
Number of Employees
219people
Average Salary
58.4M KRW
Score Calculation Basis
Detailed Financial Score
PER
2.19Industry Average 15.008.0Point
Half of industry avg (excellent)
PBR
0.35Industry Average 1.207.0Point
Half of industry avg (excellent)
ROE
15.93Industry Average 8.005.5Point
2.0x industry avg (good)
Debt Ratio
12.43Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.5 / 3
Avg ▲13.5% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼24.8% (2-year basis)
ROE Trend
4.0 / 4
Avg ROE 19.8% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position3.0Point
52w lower range (22%)
Current 4,000Won52-week high 5,98052-week low 3,440
1-month return3.0Point
1m 1.91% (flat)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral반기보고서 (2026.06)2026-08-13